77055-30-2 Usage
General Description
4-tert-Butyl-2,6-dinitroanisole, also known as tetryl, is a synthetic chemical compound commonly used as an explosive material. It is a yellow crystalline solid with a slightly sweet odor and is insoluble in water. Tetryl is highly sensitive to heat, shock, and friction, making it a dangerous material to handle. It is primarily used as a booster or intermediate explosive in military and industrial applications, and due to its high performance, it has been used in propellants, ammunition, and blasting agents. Tetryl has been classified as a hazardous material and its production, handling, and transportation are tightly regulated to prevent accidents and minimize environmental impact.
Check Digit Verification of cas no
The CAS Registry Mumber 77055-30-2 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 7,7,0,5 and 5 respectively; the second part has 2 digits, 3 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 77055-30:
(7*7)+(6*7)+(5*0)+(4*5)+(3*5)+(2*3)+(1*0)=132
132 % 10 = 2
So 77055-30-2 is a valid CAS Registry Number.
InChI:InChI=1/C11H14N2O5/c1-11(2,3)7-5-8(12(14)15)10(18-4)9(6-7)13(16)17/h5-6H,1-4H3
77055-30-2Relevant articles and documents
Novel chromene diarylurea compounds, and preparation method and application thereof
-
Paragraph 0153, (2017/08/28)
The invention relates to compounds represented by the general formula I, or isomers, pharmaceutical salts and solvates thereof; the invention also relates to a composition containing the compounds represented by the general formula I, or the isomers, the
1,4-Disubstituted benzo-fused compounds
-
, (2008/06/13)
Disclosed are novel 1,4-disubstituted benzo-fused compounds wherein G, X, L, Q, n and Y are defined herein. The compounds are useful in pharmaceutic compositions for treating diseases or pathological conditions involving inflammation such as chronic infla
Novel carbamate and oxamide compounds
-
, (2008/06/13)
Disclosed are novel aromatic compounds of the formula(I) described herein, wherein G, E, W, Ar, X, Y and Z are disclosed herein. The compounds are useful for treating cytokine mediated diseases or conditions such as chronic inflammatory diseases. Also disclosed are pharmaceutical compositions containing and processes of making such compounds.
